Ocera Therapeutics
contact us
  • home
  • about us
  • pipeline
  • therapeutic areas
  • clinical trials
  • partnering and licensing
  • news and events
  • Overview
  • Liver
    • Mild HE
    • Acute HE in Liver Cirrhosis
    • Acute HE in Acute Liver Failure
  • GI
    • Pouchitis
    • IBS

Therapeutic Areas

Liver : Acute Hepatic Encephalopathy
in Acute Liver Failure

Acute Liver Failure is defined as the onset of hepatic encephalopathy and coagulation defects in patients without pre-existing liver disease. 

Over 50% of ALF occurrences are due to acetaminophen overdose, with approximately half of these being accidental overdoses.  Mortality is high at around 30%, and some of the deaths occur while patients are waiting for liver transplant.1

In the U.S. alone, there are approximately 56,000 emergency room visits due to acetaminophen overdose each year2, and 2,000 patients3 are treated for acute liver failure annually.  The acute hepatic encephalopathy associated with ALF can lead to coma and eventually death. About a third of patients with acute liver failure will require a liver transplantation.

See also: OCR-002

 

  1. Lee et al, Hepatology, 2008;47:1401-1415
  2. Lee, Hepatology Research, 2008; 38(Suppl.1):S3-S8
  3. Lee, NEJM, 1993;Vol329:1862-1872
Copyright © 2010 Ocera Therapeutics, Inc.